Physician profile
Hani Alkhatib
NPI 1699116491
$18,943.39
in general payments reported to CMS, 2019-2025
16 companies · $3,976 in 2025
The $3,976 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $119 · 2021: $214 · 2022: $664 · 2023: $947 · 2024: $1,992 · 2025: $3,976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,992 · Travel and Lodging: $2,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,991.70 |
| Travel and Lodging | $2,923.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $9,122.41 | 2019-2020 | |
| Boston Scientific Corporation | $3,660.86 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Angiodynamics, INC. | $2,109.92 | 2025 | Angiovac, Alphavac |
| Edwards Lifesciences Corporation | $1,750.92 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,313.87 | 2021-2025 | Micra, Corevalve Evolut R, Onyx Frontier |
| Abbott Laboratories | $325.43 | 2022-2024 | Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $180.89 | 2024-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.77 | 2021-2025 | Lifevest |
| Atricure, INC. | $121.70 | 2023-2024 | |
| Astrazeneca Pharmaceuticals Lp | $66.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $47.20 | 2024 | |
| Chiesi USA, INC. | $30.14 | 2022-2023 | Cleviprex, Kengreal |
| Zoll Circulation INC | $26.71 | 2022-2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Cardiovascular Systems INC. | $25.36 | 2022 | |
| Abiomed | $18.20 | 2023 | Impella |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Alkhatib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.